![](/img/cover-not-exists.png)
PRM42 - COST MODEL OF SWITCHING FROM ENBREL TO ETANERCEPT BIOSIMILARS, FOR NON MEDICAL REASONS, IN RHEUMATOID ARTHRITIS PATIENTS IN SPAIN
Peral, C, Valderrama, M, Montoro, M, Gomez, S, Tarallo, MVolume:
21
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2018.09.2165
Date:
October, 2018
File:
PDF, 373 KB
english, 2018